EUVIMEDEUVIMED entdecken
Leitlinie

Implementation Strategies to Improve CKD Testing and Delivery of Guideline-Directed Medical Therapy

Daniel Edmonston iD, Benjamin Catanese iD, Naga Sai Akhil Reddy Gogula, Maxfield Brody iD, Rebecca D Sullenger iD, Samantha Kaplan, Sophia Wang iD, Mykenzi Davis-Cowart, Monica Leyva, Ebele Umeukeje iD, Javier Morales iD, Julienne Kirk iD und 4 weitere

Journal of the American Society of Nephrology · 12.11.2026

DOI: 10.1681/asn.0000001324 ↗

Kurz gefasst

Leitlinie in der Zeitschrift Journal of the American Society of Nephrology, online erschienen am 12.11.2026. Verfasst von Daniel Edmonston und 15 weiteren Autor:innen. Beteiligte Einrichtung: Duke University School of Medicine, Durham, North Carolina, USA.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Chronic kidney disease (CKD) remains underdiagnosed and undertreated despite substantial cardiovascular and mortality risks. Guidelines recommend annual testing with estimated glomerular filtration rate (eGFR) and urine albumin-to-creatinine ratio (UACR) in at-risk populations, and a growing number of guideline-directed medical therapies (GDMT) improve kidney and cardiovascular outcomes in CKD. We conducted a scoping review of controlled implementation studies to identify effective strategies for improving CKD testing and GDMT delivery and define priorities for future implementation trials.

Methods

Following a registered protocol and PRISMA extension for Scoping Reviews (PRISMA-ScR) guidance, we searched MEDLINE, Embase, and the Web of Science Core Collection from database inception through June 9, 2026 for English-language prospective controlled studies. Eligible studies compared an implementation strategy with usual care or another control condition. We charted study characteristics and outcomes using standardized templates and synthesized findings by objective, strategy, setting, design, and target population.

Results

We included 26 reports from 24 studies (N=7 testing, N=17 treatment). Six of 7 studies increased CKD testing, with the largest gains from patient-directed home testing and automated laboratory ordering paired with clinical decision support. However, increased testing seldom translated into increased CKD diagnosis or GDMT prescriptions. Of implementation efforts focused on CKD treatment, only 5 of 17 studies increased GDMT prescribing. Passive, single-touch strategies, including isolated alerts, one-time prompts, and registries without active outreach, rarely changed prescribing. In contrast, longitudinal strategies that incorporated pharmacist- or advanced practice provider-led management, nephrologist-supported multidisciplinary care, or proactive registry-based outreach more consistently increased GDMT exposure and sometimes improved intermediate clinical outcomes.

Conclusions

Among 24 prospective controlled studies, patient-directed home testing and automated laboratory ordering paired with clinical decision support increased CKD testing, but increased testing seldom led to CKD diagnosis or GDMT prescribing. Only 5 of 17 treatment studies increased GDMT prescribing, all through longitudinal, team-based care.

Autor:innen und Institutionen

  • Duke University School of Medicine, Durham, North Carolina, USA.
  • Duke Clinical Research Institute, Duke University, Durham, North Carolina, USA.
  • University of Pennsylvania, Philadelphia, Pennsylvania, USA.
  • North Carolina Central University, Durham, North Carolina, USA.
  • Division of Nephrology, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
  • Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Hempstead, New York, USA.

ORCID-Profile: Daniel Edmonston, Benjamin Catanese, Maxfield Brody, Rebecca D Sullenger, Sophia Wang, Ebele Umeukeje, Javier Morales, Julienne Kirk, Adrian F Hernandez, Katherine R Tuttle, Neha Pagidipati

Zitieren

APA

Edmonston, D., Catanese, B., Gogula, N. S. A. R., Brody, M., Sullenger, R. D., Kaplan, S., Wang, S., Davis-Cowart, M., Leyva, M., Umeukeje, E., Morales, J., Kirk, J., Hernandez, A. F., Tuttle, K. R., Butler, J., & Pagidipati, N. (2026). Implementation Strategies to Improve CKD Testing and Delivery of Guideline-Directed Medical Therapy. Journal of the American Society of Nephrology. https://doi.org/10.1681/asn.0000001324

Vancouver

Edmonston D, Catanese B, Gogula NSAR, Brody M, Sullenger RD, Kaplan S, et al. Implementation Strategies to Improve CKD Testing and Delivery of Guideline-Directed Medical Therapy. Journal of the American Society of Nephrology. 2026. doi:10.1681/asn.0000001324

BibTeX
@article{Edmonston2026,
  author = {Edmonston, Daniel and Catanese, Benjamin and Gogula, Naga Sai Akhil Reddy and Brody, Maxfield and Sullenger, Rebecca D and Kaplan, Samantha and Wang, Sophia and Davis-Cowart, Mykenzi and Leyva, Monica and Umeukeje, Ebele and Morales, Javier and Kirk, Julienne and Hernandez, Adrian F and Tuttle, Katherine R and Butler, Javed and Pagidipati, Neha},
  title = {Implementation Strategies to Improve CKD Testing and Delivery of Guideline-Directed Medical Therapy},
  journal = {Journal of the American Society of Nephrology},
  year = {2026},
  doi = {10.1681/asn.0000001324}
}
Kostenlos starten →